Hefei Lifeon Pharmaceutical Co., Ltd.

SZSE:003020.SZ

25.2 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 428.847333.618370.753256.711455.974811.817685.153664.961600.609628.617608.357591.089524.715549.094518.091484.161439.526452.514447.89418.3391.921391.921
Kosten van de omzet 123.063103.397111.06793.676206.526515.197452.626415.906364.042382.488371.724355.145305.956333.261345.796307.673287.112320.073307.641280.212272.477272.477
Brutowinst 305.784230.221259.685163.035249.448296.62232.526249.055236.568246.129236.633235.944218.76215.833172.295176.488152.413132.441140.25138.088119.444119.444
Brutowinstmarge 0.7130.690.70.6350.5470.3650.3390.3750.3940.3920.3890.3990.4170.3930.3330.3650.3470.2930.3130.330.3050.305
Onderzoek- en ontwikkelingskosten 11.95623.54723.92517.13430.2612.53921.41421.20817.98213.19922.96113.80516.68712.4059.5914.914.4494.3720.0016.5115.4665.466
Algemene en administratieve kosten -5.28418.046-24.65536.764-5.36615.164-23.9833.9-5.98711.666-21.1725.85-3.1859.5298.251-9.507-2.7326.174-14.6487.7667.7597.759
Verkoop- en marketingkosten 212.132158.409171.75594.887148.444183.366148.654158.218146.991162.524154.162162.014145.962143.103108.86112.95386.09385.90483.2993.96673.10173.101
Verkoop-, algemene en administratieve kosten 234.082176.455182.236131.651143.078198.53124.673192.117141.003174.19132.992187.864142.777152.632117.111103.44683.36192.07968.642101.73283.55583.555
Overige kosten -7.483-0.007-3.701-0.053-0.4814.81846.168-17.90317.7371.669-0.279-0.0442.714-0.01-0.04-1.3380.063-0.4921.4561.27300
Bedrijfskosten 253.521203.193209.862128.389197.806215.888192.255195.422176.723189.059189.841190.463176.305167.977133.386138.169109.95696.517113.88310789.70589.705
Bedrijfsresultaat 52.26329.01549.82344.31169.09677.92445.33982.67157.12854.91751.31648.2545.09247.79641.19138.57343.14734.52828.09630.71928.18428.184
Bedrijfsresultaat ratio 0.1220.0870.1340.1730.1520.0960.0660.1240.0950.0870.0840.0820.0860.0870.080.080.0980.0760.0630.0730.0720.072
Totaal overige inkomsten en kosten netto 7.6121.9815.627-0.053-0.4810.11-0.126-0.0590.039-0.086-0.2792.7265.351-0.072.2420.2240.753-1.8883.1860.9051.8551.855
Inkomen voor belasting 59.87529.00865.45144.25868.61578.03445.21382.61257.16754.83151.03848.20647.80647.78641.15138.54343.2134.03629.55231.99330.0430.04
Inkomen voor belasting ratio 0.140.0870.1770.1720.150.0960.0660.1240.0950.0870.0840.0820.0910.0870.0790.080.0980.0750.0660.0760.0770.077
Belastingkosten 9.3981.5535.4572.5573.62711.8936.15510.2336.1247.7044.1536.4485.9136.0955.6974.9276.251.3435.894.6254.625
Nettowinst 47.05930.37255.29840.24664.98866.14239.05872.3851.04347.12746.88541.75841.89341.69135.45433.61637.01129.03628.20926.10325.41525.415
Nettowinstmarge 0.110.0910.1490.1570.1430.0810.0570.1090.0850.0750.0770.0710.080.0760.0680.0690.0840.0640.0630.0620.0650.065
WPA (Winst Per Aandeel) 0.250.190.350.260.410.420.250.60.420.380.510.450.450.270.380.290.540.250.410.220.220.22
Verwaterde WPA 0.250.190.350.260.410.420.250.60.420.380.510.450.450.270.380.290.540.250.410.220.220.22
EBITDA 71.52531.12763.39942.96573.29682.14245.75285.03658.9457.58952.84148.82547.26350.22944.42343.2843.3736.20232.37336.6931.88131.881
EBITDA ratio 0.1670.0930.1710.1670.1610.1010.0670.1280.0980.0920.0870.0830.090.0910.0860.0890.0990.080.0720.0880.0810.081